Concord Biotech fundamental analysis
CONCORDBIO
1352.1
15.80 (1.18%)Last updated on 13 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Concord Biotech Fundamentals
P/E Ratio
42.65
P/B Ratio
7.56
Div. Yield
0.81
Sector P/E
69.98
Sector P/B
0.94
Sec. Div. Yield
0.57
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 42.65, compared to the sector average of 69.98. Its P/B Ratio stands at 7.56, while the sector’s is 0.94. In terms of returns, the stock offers a Dividend Yield of 0.81%, which is than the sector’s 0.57%.
Concord Biotech Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
